18/06/2024
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
18/06/2024
Jun 18, 2024, 23:25 |
Insight
The future of immuno-oncology discussion with Agenus at ESMO GI 2024
Agenus shared a post on LinkedIn: “Are you a physician attending ESMO GI 24? Join…
Jun 18, 2024, 23:17 |
Insight
Talha Badar: TP53 mutation in Myeloproliferative neoplasms
Talha Badar shared on X: , "Genomic landscape, impact allelic burden, time to…
Jun 18, 2024, 23:12 |
Insight
Koschmieder: Current standard and novel targets for myelofibrosis
Talha Badar shared on X: . "Koschmieder: current standard and novel targets…
Jun 18, 2024, 23:07 |
Insight
Palandri: State of the art talk on PV at EHA2024
Talha Badar shared on X: . "Palandri: state…
Jun 18, 2024, 23:01 |
Insight
Dr. Naval Daver presented results of ENHANCE-3 study at EHA2024
Talha Badar shared on X: . "Dr. Naval Daver: Presented results of…
Jun 18, 2024, 22:49 |
Insight
Talha Badar: Clinical outcome of AYA with Ph+ve ALL
Talha Badar shared on X: . "Clinical outcome of adolescents and young…
Jun 18, 2024, 18:51 |
Insight
Aaron Goodman: Platelets are amazing
Aaron Goodman shared a post on X: “Platelets are amazing! Lifespan: 7-10 days, Normal values: 150-450…
Jun 18, 2024, 18:40 |
Blog
Tanya Dorff: We have enjoyed having the Uromigos cup but must bid it farewell
Tanya Dorff, Division Chief of Genitourinary Disease Program at City of Hope, shared on X:…
Jun 18, 2024, 18:23 |
Insight
Matthias Guckenberger: Cancer trial participation not associated with longer OS compared to routine care
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X: “Cancer trial participation not…
Jun 18, 2024, 18:10 |
Blog
Erika Burmeister: We’re hiring a newly created position in the P and C team of Children’s Cancer Institute
Erika Burmeister, People and Culture Director at Children's Cancer Institute, posted on LinkedIn: "Are you looking…
1
2
3
4
5
All:
94
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube